Poland · Delayed Price · Currency is PLN Ryvu Therapeutics Statistics
Total Valuation
WSE:RVU has a market cap or net worth of PLN 355.59 million. The enterprise value is 368.51 million.
| Market Cap | 355.59M |
| Enterprise Value | 368.51M |
Important Dates
The last earnings date was Thursday, May 21, 2026.
| Earnings Date | May 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
WSE:RVU has 23.12 million shares outstanding. The number of shares has decreased by -4.90% in one year.
| Current Share Class | 19.07M |
| Shares Outstanding | 23.12M |
| Shares Change (YoY) | -4.90% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 23.48% |
| Owned by Institutions (%) | 41.89% |
| Float | 15.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.02 |
| PB Ratio | 8.60 |
| P/TBV Ratio | 10.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.26, with a Debt / Equity ratio of 2.32.
| Current Ratio | 2.26 |
| Quick Ratio | 2.04 |
| Debt / Equity | 2.32 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.96 |
| Interest Coverage | -7.52 |
Financial Efficiency
Return on equity (ROE) is -110.11% and return on invested capital (ROIC) is -170.00%.
| Return on Equity (ROE) | -110.11% |
| Return on Assets (ROA) | -19.70% |
| Return on Invested Capital (ROIC) | -170.00% |
| Return on Capital Employed (ROCE) | -54.86% |
| Weighted Average Cost of Capital (WACC) | 6.96% |
| Revenue Per Employee | 387,627 |
| Profits Per Employee | -388,596 |
| Employee Count | 228 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 11.96 |
Taxes
In the past 12 months, WSE:RVU has paid 254,000 in taxes.
| Income Tax | 254,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.60% in the last 52 weeks. The beta is 0.40, so WSE:RVU's price volatility has been lower than the market average.
| Beta (5Y) | 0.40 |
| 52-Week Price Change | -46.60% |
| 50-Day Moving Average | 21.35 |
| 200-Day Moving Average | 24.96 |
| Relative Strength Index (RSI) | 28.22 |
| Average Volume (20 Days) | 88,820 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, WSE:RVU had revenue of PLN 88.38 million and -88.60 million in losses. Loss per share was -3.84.
| Revenue | 88.38M |
| Gross Profit | 73.16M |
| Operating Income | -81.86M |
| Pretax Income | -88.35M |
| Net Income | -88.60M |
| EBITDA | -72.92M |
| EBIT | -81.86M |
| Loss Per Share | -3.84 |
Balance Sheet
The company has 83.11 million in cash and 96.03 million in debt, with a net cash position of -12.93 million or -0.56 per share.
| Cash & Cash Equivalents | 83.11M |
| Total Debt | 96.03M |
| Net Cash | -12.93M |
| Net Cash Per Share | -0.56 |
| Equity (Book Value) | 41.33M |
| Book Value Per Share | 1.79 |
| Working Capital | 65.15M |
Cash Flow
In the last 12 months, operating cash flow was -92.76 million and capital expenditures -7.41 million, giving a free cash flow of -100.17 million.
| Operating Cash Flow | -92.76M |
| Capital Expenditures | -7.41M |
| Depreciation & Amortization | 8.94M |
| Net Borrowing | -2.93M |
| Free Cash Flow | -100.17M |
| FCF Per Share | -4.33 |
Margins
Gross margin is 82.77%, with operating and profit margins of -92.62% and -100.25%.
| Gross Margin | 82.77% |
| Operating Margin | -92.62% |
| Pretax Margin | -99.96% |
| Profit Margin | -100.25% |
| EBITDA Margin | -82.51% |
| EBIT Margin | -92.62% |
| FCF Margin | n/a |
Dividends & Yields
WSE:RVU does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.90% |
| Shareholder Yield | 4.90% |
| Earnings Yield | -24.92% |
| FCF Yield | -28.17% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for WSE:RVU is 33.62, which is 118.60% higher than the current price. The consensus rating is "Buy".
| Price Target | 33.62 |
| Price Target Difference | 118.60% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 8.49% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
WSE:RVU has an Altman Z-Score of 0.34 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.34 |
| Piotroski F-Score | 2 |